M. R. M. Tehrani

Assessment of maximum tolerated dose of a new herbal drug, Semelil (ANGIPARSTM) in patients with diabetic foot ulcer: A Phase I clinical trial

A. Keshtkar, Heshmat Ramin, K. Mohammad, 2008 .

ANTIGLIADIN ANTIBODY IN DIABETIC PATIENTS

R. Malekzadeh, M. Mahmoudi, M. R. M. Tehrani, 2004 .

Osteoporosis, prevention, diagnosis and treatment

M. R. M. Tehrani, Ardeshir Larijani Mohammad Bagher, Z. Hamidi, 2005 .